In this cohort, the level of all cytokines showed a trend toward increase in patients treated for less than 12 months compared to untreated patients, while, except for IL-17A, they decreased markedly in patients treated for more than 24 months.
← all excerpts
Association of cytokine levels with treatment duration and patient family history in Egyptian multiple sclerosis patients.
1
—
—